Literature DB >> 15221081

[Infections under immunosuppressive therapy following organ transplantation].

L Renders1, H Schöcklmann, U Kunzendorf.   

Abstract

The risk to acquire opportunistic infections is clearly increased in patients receiving immunosuppressive therapeutic regimens following organ transplantation or during treatment of autoimmune disorders. The modulation of the immune system can alter the clinical symptoms and the course of infectious diseases, including diagnostic signs such as fever or pathological changes in radiographs or blood cell counts. However, a rapid diagnosis and start of treatment is essential in these patients. Thus, a correct interpretation of even mild symptoms in the initial phase of an infectious disease is essential for establishing a diagnosis and initiation of a therapy at an early stage. Therefore, it is necessary that the clinical hallmarks of these diseases are widely known and that physicians treating these patients cooperate closely with transplant centers.

Entities:  

Mesh:

Year:  2004        PMID: 15221081     DOI: 10.1007/s00108-004-1234-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  67 in total

1.  Transplantation-associated malignancies: restriction of human herpes virus 8 to Kaposi's sarcoma.

Authors:  G Cathomas; M Tamm; C E McGandy; P H Itin; F Gudat; G Thiel; M J Mihatsch
Journal:  Transplantation       Date:  1997-07-15       Impact factor: 4.939

Review 2.  Comparative assessment of the detection of candidal antigens as a diagnostic tool.

Authors:  R C Matthews
Journal:  J Med Vet Mycol       Date:  1996 Jan-Feb

3.  Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.

Authors:  M A Fisher; S H Shen; J Haddad; W F Tarry
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 4.  Infections in liver transplant recipients.

Authors:  D J Winston; C Emmanouilides; R W Busuttil
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

Review 5.  Pneumocystis carinii and parasitic infections in transplantation.

Authors:  J A Fishman
Journal:  Infect Dis Clin North Am       Date:  1995-12       Impact factor: 5.982

6.  Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

Authors:  D H Kedes; D Ganem
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 7.  Polyomavirus nephropathy: morphology, pathophysiology, and clinical management.

Authors:  Volker Nickeleit; Harsharan K Singh; Michael J Mihatsch
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-11       Impact factor: 2.894

8.  Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia.

Authors:  K M Jules-Elysee; D E Stover; M B Zaman; E M Bernard; D A White
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

9.  Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children.

Authors:  L L Pifer; W T Hughes; S Stagno; D Woods
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

10.  Molecular histogenesis of posttransplantation lymphoproliferative disorders.

Authors:  Daniela Capello; Michaela Cerri; Giuliana Muti; Eva Berra; Pierluigi Oreste; Clara Deambrogi; Davide Rossi; Giampietro Dotti; Annarita Conconi; Mario Viganò; Umberto Magrini; Giovanbattista Ippoliti; Enrica Morra; Annunziata Gloghini; Alessandro Rambaldi; Marco Paulli; Antonino Carbone; Gianluca Gaidano
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.